SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as it announced ceasing its compounded semaglutide pill offering following FDA threats and a DOJ referral, sparking intense community debate on whether this move resolves regulatory uncertainty or highlights significant risks for the telehealth provider.

OpenAI pioneers large-language models like GPT and DALL·E, enabling advanced AI applications. Their research emphasizes both cutting-edge capability and responsible deployment strategies.

OpenAI PreStocks

OPENAI CRYPTO is trending amidst widespread community skepticism, with users predominantly identifying it as an unofficial scam or unauthorized "pre-stock" attempting to capitalize on the high public interest in the actual OpenAI company's potential future offering, sparking debates on its legitimacy.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is trending as community discussion intensifies around its status as an undervalued "safety" stock with a high dividend yield and anticipated strong earnings, even as a significant debate rages over Berkshire Hathaway's recent filing to potentially sell its large stake.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo Finance is trending due to its rapid expansion in real-world asset tokenization, including launching over 200 tokenized assets on Solana and receiving EU regulatory approval, further bolstered by the SEC's decision to close its investigation without charges. The community is split between bullish sentiment for its institutional partnerships and RWA leadership, and concerns over the potential impact of upcoming large token unlocks.

HOPPY is a memecoin launched on Ethereum as a tribute to the frog from the famous comic book «The Night Riders», published in 2012 by artist and illustrator Matt Furie, which has gained popularity.   HOPPY appeals to the cryptocurrency community with its no-tax policy and transparent acknowledgment of its lack of utility, maintaining the essence of a pure and simple memecoin.

Hoppy

HOPPY CRYPTO is trending due to its pivotal role as the "second frog" in the popular "three frog narrative," positioning it as a high-potential beta play to the established PEPE coin. The community is actively discussing its connection to Matt Furie and its lower market cap as a compelling opportunity for significant gains.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending due to its highly active community's unwavering bullish conviction and relentless promotion of its 'mind virus' meme culture, anticipating a massive viral spread and significant gains during the burgeoning Solana memecoin season.

Ankr is a Web3 decentralized infrastructure provider that helps developers, dapps, and stakers easily interact with multiple blockchains. It allows you to create DApps using API and RPC, staking on Ankr Earn, and use customized blockchain solutions for businesses.

Ankr Network

Ankr Network ($ANKR) is trending amidst sharply divided sentiment, with proponents highlighting recent developments in Web3 infrastructure, AI-focused L2 solutions, and security audits positioning it as an undervalued industry backbone with potential token burns. Conversely, a vocal part of the community expresses deep frustration, labeling it a "scam" due to prolonged price stagnation and a perceived failure to move with the broader cryptocurrency market.

$Goldcoin: the gold standard on Solana. All PumpFun CTO Creator Rewards are allocated 50% for buybacks &amp; burns and 50% for marketing + development daily. Full transparent CTO leadership providing on-chain + social proof evidence of all transactions. We provide provide daily Token Improvement Reports that highlight all the reward claims, allocations, showing 50% buyback and burn transactions, and all marketing expense transactions for $Goldcoin every day.  Community CTO involved in voting and decision-making as often as possible.

goldcoin

GOLDCOIN is trending amidst community excitement over its extremely low market cap and active daily token burn mechanism, positioning the Solana-based token as a high-potential "digital gold" with significant upside.

CD Projekt SA is a holding company, which engages in the development of video games. It operates through the CD PROJEKT RED and GOG.com segments. The CD PROJEKT RED segment focuses on videogame development. The GOG.com segment distributes global digital videogame. Its other activities include motion picture distribution and investment services. The company was founded by Marcin Piotr Iwinski in 1994 and is headquartered in Warsaw, Poland.

CD Projekt S.A. - ADR

CD Projekt 4 ADR Representing Ord Shs

CD Projekt is generating significant buzz as The Witcher 4 enters full production, fueled by fervent community speculation surrounding a potential new Witcher 3 expansion and sustained strong sales of Cyberpunk 2077. Investors and fans are actively discussing the company's robust financial performance, including its debt-free status and strong earnings, alongside its stated commitment to human creativity over AI in game development.

Ecolab, Inc. engages in providing products and services in the field of water, hygiene, and energy. It operates through the following segments: Global Industrial, Global Institutional and Specialty, Global Healthcare and Life Sciences, Global Pest Elimination, and Corporate. The Global Industrial segment relates to water, food and beverage, paper, and downstream operating segments. The Global Institutional and Specialty segment refers to the institutional, specialty, and healthcare operating segments. The Global Healthcare and Life Sciences segment includes the healthcare and life sciences operations. The Global Pest Elimination segment provides services designed to detect, prevent and eliminate pests, such as rodents and insects, in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other. The company was founded by Merritt J. Osborn in 1923 and is headquartered in St. Paul, MN.

Ecolab, Inc.

Ecolab is trending due to its strategic expansion into high-tech water and cooling solutions for the rapidly growing AI data center market, fueling community discussion around its resilient business model and potential as a long-term, innovation-driven compounder in water and hygiene.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Campbell & CO Investment Adviser LLC Takes Position in Fulcrum Therapeutics, Inc. $FULC

Campbell & CO Investment Adviser LLC acquired a new position in shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC - Free Report) during the third quarter, according to its most recent 13F filing with...

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Fulcrum Therapeutics, Inc. (NASDAQ:FULC - Get Free Report) has earned a consensus rating of "Moderate Buy" from the twelve research firms that are covering the firm, Marketbeat Ratings reports. Three...

Fulcrum Therapeutics (NASDAQ:FULC) Cut to Sell at Wall Street Zen

Wall Street Zen lowered shares of Fulcrum Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...

Fulcrum Therapeutics (NASDAQ:FULC) Shares Gap Up - Should You Buy?

Fulcrum Therapeutics (NASDAQ:FULC) Shares Gap Up - Still a Buy...

Fulcrum Therapeutics (NASDAQ:FULC) Coverage Initiated by Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co. began coverage on shares of Fulcrum Therapeutics in a report on Monday. They set an "overweight" rating and a $20.00 price target for the company...

Fulcrum Therapeutics (NASDAQ:FULC) Director Robert Gould Sells 15,000 Shares

Fulcrum Therapeutics, Inc. (NASDAQ:FULC - Get Free Report) Director Robert Gould sold 15,000 shares of Fulcrum Therapeutics stock in a transaction dated Friday, January 2nd. The shares were sold at...

Fulcrum Therapeutics (NASDAQ:FULC) Stock Price Down 5.4% - Should You Sell?

Fulcrum Therapeutics (NASDAQ:FULC) Shares Down 5.4% - Here's Why...

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Sees Significant Decrease in Short Interest

Fulcrum Therapeutics, Inc. (NASDAQ:FULC - Get Free Report) saw a large decline in short interest in December. As of December 15th, there was short interest totaling 2,994,328 shares, a decline of...

Fulcrum Therapeutics (NASDAQ:FULC) Trading Down 4.3% - Time to Sell?

Fulcrum Therapeutics (NASDAQ:FULC) Trading Down 4.3% - Here's Why...

Wall Street Analysts Think Fulcrum Therapeutics (FULC) Could Surge 58.47%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 58.5% in Fulcrum Therapeutics (FULC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015, and is headquartered in Cambridge, MA.

Fulcrum Therapeutics Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Current Price	$9.74
Prev Close	$9.55
Open	$9.71
Dividend Yield	0.00%
50-Day Moving Average	$11.02
Beta	1.57
Avg. Volume	777,958.15
PE Ratio	-8.26

52-Week High	$15.74
52-Week Low	$2.32
Market Capitalization	$642.55M
EPS (Annual)	-$0.1569
Price to Book	2.66
Revenue Per Employee	$1.78M
Enterprise Value/EBITDA	N/A

FULC
Fulcrum Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FULC News

FULCFulcrum Therapeutics Inc